> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Sebela Pharma Sutab Tablets OK’d for Colon Prep
- URL: https://www.fdaweb.com/sebela-pharma-sutab-tablets-okd-for-colon-prep/
- Published: 2020-11-11T12:00:00.000Z
- Updated: 2026-09-14T16:35:58.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5148068

FDA has approved a Sebela Pharmaceuticals NDA for Sutab (sodium sulfate, magnesium sulfate, and potassium chloride) tablets, indicated for colonoscopy preparation. The product was designed to give patients and physicians an alternative to liquid-based colonoscopy preparations. Approval was based on data from two pivotal trials showing that 92% of patients achieved successful bowel cleansing with Sutab, according to the company. Seventy-eight percent said they would request Sutab again for a future colonoscopy, it says. On the safety side, more Sutab patients reported experiencing nausea and vomiting than the comparator, with less than 1% of these reports considered severe.